Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity - PubMed (original) (raw)
. 1999 Jul 2;274(27):18902-8.
doi: 10.1074/jbc.274.27.18902.
Affiliations
- PMID: 10383387
- DOI: 10.1074/jbc.274.27.18902
Free article
Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity
C Blanpain et al. J Biol Chem. 1999.
Free article
Abstract
CCR5 is the major coreceptor for macrophage-tropic human immunodeficiency virus type I (HIV-1). For most G-protein-coupled receptors that have been tested so far, the disulfide bonds linking together the extracellular loops (ECL) are required for maintaining the structural integrity necessary for ligand binding and receptor activation. A natural mutation affecting Cys20, which is thought to form a disulfide bond with Cys269, has been described in various human populations, although the consequences of this mutation for CCR5 function are not known. Using site-directed mutagenesis, we mutated the four extracellular cysteines of CCR5 singly or in combination to investigate their role in maintaining the structural conformation of the receptor, its ligand binding and signal transduction properties, and its ability to function as a viral coreceptor. Alanine substitution of any single Cys residue reduced surface expression levels by 40-70%. However, mutation of Cys101 or Cys178, predicted to link ECL1 and ECL2 of the receptor, abolished recognition of CCR5 by a panel of conformation sensitive anti-CCR5 antibodies. The effects of the mutations on receptor expression and conformation were partially temperature-sensitive, with partial restoration of receptor expression and conformation achieved by incubating cells at 32 degrees C. All cysteine mutants were unable to bind detectable levels of MIP-1beta, and did not respond functionally to CCR5 agonists. Surprisingly, all cysteine mutants did support infection by R5 strains of HIV, though at reduced levels. These results indicate that both disulfide bonds of CCR5 are necessary for maintaining the structural integrity of the receptor necessary for ligand binding and signaling. Env binding and the mechanisms of HIV entry appear much less sensitive to alterations of CCR5 conformation.
Similar articles
- Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM, Wang ZX, Trent JO, Murray JL, Hu QX, DeLeeuw L, Moore PS, Chang Y, Peiper SC. Navenot JM, et al. J Mol Biol. 2001 Nov 9;313(5):1181-93. doi: 10.1006/jmbi.2001.5086. J Mol Biol. 2001. PMID: 11700073 - Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding.
Bondue A, Jao SC, Blanpain C, Parmentier M, LiWang PJ. Bondue A, et al. Biochemistry. 2002 Nov 19;41(46):13548-55. doi: 10.1021/bi026087d. Biochemistry. 2002. PMID: 12427015 - Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
Maeda Y, Foda M, Matsushita S, Harada S. Maeda Y, et al. J Virol. 2000 Feb;74(4):1787-93. doi: 10.1128/jvi.74.4.1787-1793.2000. J Virol. 2000. PMID: 10644351 Free PMC article. - Macrophage inflammatory protein-1.
Menten P, Wuyts A, Van Damme J. Menten P, et al. Cytokine Growth Factor Rev. 2002 Dec;13(6):455-81. doi: 10.1016/s1359-6101(02)00045-x. Cytokine Growth Factor Rev. 2002. PMID: 12401480 Review. - Receptor conformation and constitutive activity in CCR5 chemokine receptor function and HIV infection.
Flanagan CA. Flanagan CA. Adv Pharmacol. 2014;70:215-63. doi: 10.1016/B978-0-12-417197-8.00008-0. Adv Pharmacol. 2014. PMID: 24931198 Review.
Cited by
- Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance.
Romano Ibarra GS, Paul B, Sather BD, Younan PM, Sommer K, Kowalski JP, Hale M, Stoddard B, Jarjour J, Astrakhan A, Kiem HP, Rawlings DJ. Romano Ibarra GS, et al. Mol Ther Nucleic Acids. 2016 Aug 23;5(8):e352. doi: 10.1038/mtna.2016.56. Mol Ther Nucleic Acids. 2016. PMID: 27741222 Free PMC article. - Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist vicriviroc.
Ogert RA, Ba L, Hou Y, Buontempo C, Qiu P, Duca J, Murgolo N, Buontempo P, Ralston R, Howe JA. Ogert RA, et al. J Virol. 2009 Dec;83(23):12151-63. doi: 10.1128/JVI.01351-09. Epub 2009 Sep 23. J Virol. 2009. PMID: 19776131 Free PMC article. - Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1.
Kuhmann SE, Platt EJ, Kozak SL, Kabat D. Kuhmann SE, et al. J Virol. 2000 Aug;74(15):7005-15. doi: 10.1128/jvi.74.15.7005-7015.2000. J Virol. 2000. PMID: 10888639 Free PMC article. - Molecular cloning and characterization of the allatotropin precursor and receptor in the desert locust, Schistocerca gregaria.
Lismont E, Vleugels R, Marchal E, Badisco L, Van Wielendaele P, Lenaerts C, Zels S, Tobe SS, Vanden Broeck J, Verlinden H. Lismont E, et al. Front Neurosci. 2015 Mar 12;9:84. doi: 10.3389/fnins.2015.00084. eCollection 2015. Front Neurosci. 2015. PMID: 25814925 Free PMC article. - Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.
Kenakin T, Miller LJ. Kenakin T, et al. Pharmacol Rev. 2010 Jun;62(2):265-304. doi: 10.1124/pr.108.000992. Epub 2010 Apr 14. Pharmacol Rev. 2010. PMID: 20392808 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases